DLA Piper advised sales agents Needham & Company (Needham) and B. Riley Securities, Inc. (B. Riley) in the offering. Rigetti Computing, Inc. (Rigetti), a quantum computing...
Rigetti Computing’s US$100 Million At-The-Market Offering
Klaviyo’s $576 Million Initial Public Offering
Goodwin Procter advised Klaviyo, and Sidley Austin advised the underwriters on the offering. Klaviyo, Inc. announced the pricing of its initial public offering of 19,200,000 shares of...
Cerence’s $190 Million Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. Cerence Inc. (NASDAQ: CRNC) announced the pricing of $190.0 million aggregate principal amount of 1.50% convertible...
Mobileye’s $1.617 Billion Secondary Offering
Davis Polk & Wardwell LLP advised Mobileye Global Inc on the offering, while Sullivan & Cromwell LLP advised the underwriters. Mobileye Global Inc., a leader of the...
EVgo’s $125 Million Public Equity Offering
Freshfields Bruckhaus advised EVgo, and Latham & Watkins advised the underwriters. EVgo Inc. announced the pricing on May 17, 2023 of an underwritten public offering of 29,411,765...
Vaxcyte’s $500 Million Public Offering
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
EngageSmart’s Public Offering
Latham & Watkins advised EngageSmart, Fenwick & West advised the underwriters, Paul Weiss, Kirkland & Ellis LLP, Maples and Calder (Cayman) and Whalen, respectively, advised certain...
Geron Corporation’s $198 Million Upsized Public Offering
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
SkyWater Technology’s $17.25 Million Rights Offering
Goodwin Procter advised Needham & Company on the deal. SkyWater Technology, Inc. announced the offering of its common stock for an aggregate amount of $17.25 million. The...
Recursion Pharmaceuticals’ $150 Million Private Placement
Davis Polk advised the placement agents in the transaction. Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the...
Vaxcyte’s $690 Million Public Offering
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
Liquidia’s $50 Million Common Stock Offering
DLA Piper represented Liquidia, while Latham & Watkins represented the underwriters in the offering. Liquidia Corporation, a biopharmaceutical company focused on the development and commercialization of...